Schedule 13G ownership disclosure
EVOKE PHARMA INC
Common Shares · CUSIP: 30049G203
Event date: 2025-03-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bleichroeder LP
Shares: 849,367 · Class: 9.99%
- Bleichroeder Holdings LLC
Shares: 849,367 · Class: 9.99%
- Andrew Gundlach
Shares: 849,367 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001420506-25-000689
- Form type
- SCHEDULE 13G/A
- Filer
- Bleichroeder LP
- CIK
- CIK 1781002
- Filed
- Mar 21, 2025
- Reporting period
- Mar 19, 2025
- Description
- Schedule 13G beneficial ownership